NYHA functional class | LVEF study (%) | |||||||
---|---|---|---|---|---|---|---|---|
Patient no. | Sex | Age (y) | Diagnosis | Before study | At time of study | At time of annexin imaging | After 1 y of follow-up | Outcome of annexin A5 study |
1 | M | 63 | DCM | III | III | 25 | 30 | Negative |
2 | M | 35 | DCM | II | II | 26 | 50 | Negative |
3 | F | 39 | DCM | I | III | 45 | 46 | Focal |
4 | M | 52 | DCM | III | III | 31 | 34 | Negative |
5 | M | 50 | DCM | III | III | 17 | 22 | Negative |
6 | M | 58 | DCM | II | IV | 48 | 24 | Focal, mainly lateral |
7 | F | 64 | DCM | II | III | 21 | 15 | Multifocal |
8 | F | 41 | DCM | III | IV | 20 | 22 | Negative |
9 | F | 33 | HCM | II | IV | 26 | 15 | Positive, diffuse, left ventricular |
10 | F | 36 | HCM | I | I | 52 | NA | Negative |
11 | F | 37 | HCM | I | I | 73 | NA | Negative |
NYHA = New York Heart Association; DCM = dilated cardiomyopathy; HCM = hypertrophic cardiomyopathy; NA = not applicable.